Published in World J Stem Cells on April 26, 2014
Anti-CD73 in cancer immunotherapy: awakening new opportunities. Trends Cancer (2016) 0.90
Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Front Cell Neurosci (2015) 0.82
Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair. World J Stem Cells (2016) 0.81
Calcium-gated K(+) channels of the KCa1.1- and KCa3.1-type couple intracellular Ca(2+) signals to membrane hyperpolarization in mesenchymal stromal cells from the human adipose tissue. Pflugers Arch (2016) 0.79
The role of purinergic receptors in stem cell differentiation. Comput Struct Biotechnol J (2014) 0.78
The burning questions of heterotopic ossification. Ann Transl Med (2015) 0.77
Multiple Functions of MSCA-1/TNAP in Adult Mesenchymal Progenitor/Stromal Cells. Stem Cells Int (2015) 0.76
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Receptors for purines and pyrimidines. Pharmacol Rev (1998) 13.92
Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med (2007) 10.00
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet (1970) 7.16
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells (2001) 6.86
Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem (1997) 6.30
Adenosine receptors as therapeutic targets. Nat Rev Drug Discov (2006) 6.15
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res (2009) 4.58
Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med (2004) 4.16
Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med (2004) 4.16
Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther (2006) 3.93
Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev (2006) 3.82
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal (2006) 3.52
CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med (2002) 3.18
Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol (2005) 3.15
Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal (2006) 2.98
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev (2008) 2.92
Regulation of osteoblast differentiation by transcription factors. J Cell Biochem (2006) 2.86
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Extracellular ATP as a signaling molecule for epithelial cells. Biochim Biophys Acta (2003) 2.54
Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol (2001) 2.36
Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci (2006) 2.32
Adipogenesis: forces that tip the scales. Trends Endocrinol Metab (2001) 2.30
Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol (2002) 2.28
Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet (2003) 2.23
NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci (2005) 2.08
Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta (2003) 2.00
The role of mesenchymal stem cells in haemopoiesis. Blood Rev (2005) 1.98
A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo. J Biol Chem (2012) 1.88
Mesenchymal stem cell preparations--comparing apples and oranges. Stem Cell Rev (2007) 1.88
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol (1997) 1.88
Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol (2012) 1.81
Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 1.78
CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem (1996) 1.78
Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev (2010) 1.78
Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol (2005) 1.76
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev (2001) 1.76
Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol (2006) 1.71
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood (2007) 1.70
Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci (2007) 1.61
Tumor-promoting functions of adenosine. Pharmacol Ther (2000) 1.58
Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy (2008) 1.51
Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med (2009) 1.49
Evolutionary origins of the purinergic signalling system. Acta Physiol (Oxf) (2009) 1.46
Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults. J Clin Endocrinol Metab (2008) 1.44
P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol (2004) 1.35
Enzymes involved in purine metabolism--a review of histochemical localization and functional implications. Histol Histopathol (1999) 1.33
Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther (2013) 1.32
Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab (2007) 1.29
Multiplicity of Ca2+ messengers and Ca2+ stores: a perspective from cyclic ADP-ribose and NAADP. Curr Mol Med (2004) 1.29
Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. J Bone Miner Res (2005) 1.27
P2 receptors: new potential players in atherosclerosis. Br J Pharmacol (2002) 1.27
Adenosine receptors as drug targets. Exp Cell Res (2010) 1.27
Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J Biol Chem (2006) 1.24
ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium (2006) 1.22
Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res (2011) 1.19
Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function. Gastroenterology (1999) 1.19
CD73-generated adenosine promotes osteoblast differentiation. J Cell Physiol (2012) 1.18
Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther (2008) 1.17
Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J (2002) 1.12
Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma. FASEB J (2013) 1.08
Adenosine 5-diphosphate-ribose is a neural regulator in primate and murine large intestine along with β-NAD(+). J Physiol (2012) 1.07
Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal (2006) 1.07
Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum (2013) 1.05
Bone acquisition in healthy young females is reciprocally related to marrow adiposity. J Clin Endocrinol Metab (2010) 1.04
K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study. Br J Pharmacol (2012) 1.04
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling. Blood (2012) 1.03
The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. Bone (2010) 1.02
Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost (2003) 1.01
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. Stem Cells Dev (2012) 1.01
Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol (2008) 1.00
ATP and adenosine act as a mitogen for osteoblast-like cells (MC3T3-E1). Calcif Tissue Int (1996) 0.98
Evidence for coordinated induction and repression of ecto-5'-nucleotidase (CD73) and the A2a adenosine receptor in a human B cell line. Biol Chem (2003) 0.98
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells (2007) 0.98
Extracellular cyclic ADP-ribose increases intracellular free calcium concentration and stimulates proliferation of human hemopoietic progenitors. FASEB J (2000) 0.97
Purinergic receptors influence the differentiation of human mesenchymal stem cells. Stem Cells Dev (2011) 0.97
Concentrative uptake of cyclic ADP-ribose generated by BST-1+ stroma stimulates proliferation of human hematopoietic progenitors. J Biol Chem (2004) 0.96
CD73/5'-ecto-nucleotidase acts as a regulatory factor in osteo-/chondrogenic differentiation of mechanically stimulated mesenchymal stromal cells. Eur Cell Mater (2013) 0.96
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. Exp Hematol (2010) 0.95
Adenosine A2a receptor activation delays apoptosis in human neutrophils. J Immunol (1997) 0.94
Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J Cell Physiol (2010) 0.94
Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Exp Cell Res (2004) 0.93
Rat pancreas secretes particulate ecto-nucleotidase CD39. J Physiol (2003) 0.92
Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors. Stem Cells (2013) 0.92
Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol (2001) 0.91
Cyclic ADP-ribose-mediated expansion and stimulation of human mesenchymal stem cells by the plant hormone abscisic acid. Stem Cells (2008) 0.89
Extracellular NAD(+) induces a rise in [Ca(2+)](i) in activated human monocytes via engagement of P2Y(1) and P2Y(11) receptors. Cell Calcium (2009) 0.87
Paracrinally stimulated expansion of early human hemopoietic progenitors by stroma-generated cyclic ADP-ribose. FASEB J (2001) 0.86
Ecto-enzymes of lymphoid cells. Immunol Rev (1998) 0.86
Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. Stem Cells Dev (2010) 0.85
The plant hormone abscisic acid stimulates the proliferation of human hemopoietic progenitors through the second messenger cyclic ADP-ribose. Stem Cells (2009) 0.84
Cyclopentyladenosine improves cell proliferation, wound healing, and hair growth. J Surg Res (1999) 0.84
Cyclic ADP ribose is a novel regulator of intracellular Ca2+ oscillations in human bone marrow mesenchymal stem cells. J Cell Mol Med (2011) 0.84
Cyclic ADP-ribose generation by CD38 improves human hemopoietic stem cell engraftment into NOD/SCID mice. FASEB J (2002) 0.83
Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes. Stem Cells (2013) 0.81
Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair. World J Stem Cells (2016) 0.81